Epilepsy treatment: Precision medicine at a crossroads

Dick Lindhout

doi:10.1016/S1474-4422(15)00295-1

Epilepsy treatment: Precision medicine at a crossroads

Dick Lindhout^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1148-1149
Number of pages	2
Journal	Lancet Neurology
Volume	14
Issue number	12
DOIs	https://doi.org/10.1016/S1474-4422(15)00295-1
Publication status	Published - 1 Dec 2015

Keywords

ANTIEPILEPTIC DRUGS
GILBERTS-SYNDROME
RISK

Access to Document

10.1016/S1474-4422(15)00295-1

Cite this

@article{0998ca0d1444455ea89e54fb7273ef93,

title = "Epilepsy treatment: Precision medicine at a crossroads",

keywords = "ANTIEPILEPTIC DRUGS, GILBERTS-SYNDROME, RISK",

author = "Dick Lindhout",

year = "2015",

month = dec,

day = "1",

doi = "10.1016/S1474-4422(15)00295-1",

language = "English",

volume = "14",

pages = "1148--1149",

journal = "Lancet Neurology",

issn = "1474-4422",

publisher = "Elsevier Limited",

number = "12",

}

TY - JOUR

T1 - Epilepsy treatment

T2 - Precision medicine at a crossroads

AU - Lindhout, Dick

PY - 2015/12/1

Y1 - 2015/12/1

KW - ANTIEPILEPTIC DRUGS

KW - GILBERTS-SYNDROME

KW - RISK

UR - https://www.scopus.com/pages/publications/84946730088

U2 - 10.1016/S1474-4422(15)00295-1

DO - 10.1016/S1474-4422(15)00295-1

M3 - Article

AN - SCOPUS:84946730088

SN - 1474-4422

VL - 14

SP - 1148

EP - 1149

JO - Lancet Neurology

JF - Lancet Neurology

IS - 12

ER -

Epilepsy treatment: Precision medicine at a crossroads

Keywords

Access to Document

Other files and links

Cite this